(19)
(11) EP 1 272 190 A2

(12)

(88) Date of publication A3:
16.05.2002

(43) Date of publication:
08.01.2003 Bulletin 2003/02

(21) Application number: 01919406.7

(22) Date of filing: 28.03.2001
(51) International Patent Classification (IPC)7A61K 31/55, A61P 25/28
(86) International application number:
PCT/EP0103/551
(87) International publication number:
WO 0107/4364 (11.10.2001 Gazette 2001/41)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 03.04.2000 US 194262 P

(71) Applicant: JANSSEN PHARMACEUTICA N.V.
2340 Beerse (BE)

(72) Inventors:
  • PARYS, Wim, Louis, Julien
    Gaithersburg, MD 20882 (US)
  • PONTECORVO, Michael
    Lawrenceville, NJ 08648 (US)

(74) Representative: Quaghebeur, Luc 
Janssen Pharmaceutica N.V.,J&J Patent Law Department,Turnhoutseweg 30
2340 Beerse
2340 Beerse (BE)

   


(54) A USE OF GALANTAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE; TARGETING THE UNDERLYING CAUSE OF THE DISEASE